13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

Also called NCT02492438

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 154 participants (enrolled count) (from the registry)
Sponsor
  • AZ Sint-Jan AV Registry lists this organization as the lead sponsor
  • Pfizer Registry lists this organization as a collaborator
Registry
  • NCT NCT02492438
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02492438. Non-randomized; no masking; primary purpose prevention. Start 2013-02 (registry gives no type); primary completion 2014-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients
Condition
Chronic Kidney Failure
Intervention (Biological)
PPV23 vaccination or PCV13 vaccination
Lead sponsor
AZ Sint-Jan AV (class: other)
Collaborator
Pfizer (class: industry)

Record details

Record id
cardio:ct-nct02492438
Content hash
4dc51d79cf7637679275ca2adb0db0dde1e837dc456c0e464af3291d1d4e56f4